Did Biden Admin 'Play Nice' In Medicare Drug Price Talks?
In announcing the first agreements under Medicare's new drug price negotiating authority, the Biden administration took great pains to undermine one of the industry's central legal and rhetorical challenges to the...To view the full article, register now.
Already a subscriber? Click here to view full article